55 results
Page 2 of 3
8-K
EX-10.1
ou93tzaky3hkk630t9tt
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
424B5
rvkcdsv48lr 2llmil
2 Jun 20
Prospectus supplement for primary offering
5:05pm
8-K
EX-1.1
uf5sevx2 kdomu4wvpx
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
424B5
b2omr6804wia jca1mwx
1 Jun 20
Prospectus supplement for primary offering
6:06am
8-K
EX-10.1
wmgf5ewx yyx
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
424B5
30i8fvjtoawqs
22 Jan 20
Prospectus supplement for primary offering
5:31pm
8-K
EX-1.1
kl2mffb65qfpp1143bf
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm
424B5
az6 l1saajsl
21 Jan 20
Prospectus supplement for primary offering
5:21pm
8-K
EX-10.1
njeth7c
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
7qkfgppfxsp
1 Oct 19
Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer
8:14am
8-K
EX-10.1
avhop8ne8khghzpw846
1 Aug 19
New Executive Team Announced at Adaptimmune
7:22am
8-K
EX-10.4
2om4u4
27 Jun 19
Departure of Directors or Certain Officers
8:08am
8-K
EX-10.1
ynv5yeftm2vo
27 Jun 19
Departure of Directors or Certain Officers
8:08am